Rankings
Pricing
Log In
Free Trial
US-listed companies
Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc.
TARS
Market cap
$1.1B
P/E ratio
Add to your list
Add to your list
Back to summarized table
B
M
K
USD
iso4217:USD
Annual
Quarterly
Download CSV
Income statement
Balance sheet
Cash flow
Dec 31,
2023
Cash and cash equivalents
225
Marketable securities
2
Other receivables
1
Accounts receivable, net
17
Prepaid expenses
8
Inventory
3
Total current assets
256
Other receivables
1
Prepaid expenses
8
Total current assets
256
Property and equipment, net
1
Operating lease right-of-use assets
2
Intangible assets, net
4
Long-term investments
1
Operating lease right-of-use assets
2
Other assets
2
Long-term investments
1
Total assets
265
Other assets
2
Total assets
265
Accounts payable and other accrued liabilities
24
Accrued payroll and benefits
13
Total current liabilities
37
Term loan, net
30
Other long-term liabilities
2
Total liabilities
69
Common Stock, Value, Issued
0
Additional paid-in capital
442
Accumulated other comprehensive loss
-0
Accumulated deficit
-245
Total stockholders’ equity
197
Total liabilities and stockholders’ equity
265